Clinical Trial Update: Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating the effect of rosuvastatin on creatine kinase leak at the time of percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Kleber Bomfim Araujo Martins | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN